TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends

NCT07736846 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

DRUG: treprostinil

Sponsor

AOP Orphan Pharmaceuticals AG